These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9378961)

  • 21. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
    El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
    J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease.
    Buhlmann JE; Gonzalez M; Ginther B; Panoskaltsis-Mortari A; Blazar BR; Greiner DL; Rossini AA; Flavell R; Noelle RJ
    J Immunol; 1999 Apr; 162(8):4373-6. PubMed ID: 10201970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8(+)CD103(+) regulatory T cells in spontaneous tolerance of liver allografts.
    Lu L; Yu Y; Li G; Pu L; Zhang F; Zheng S; Wang X
    Int Immunopharmacol; 2009 May; 9(5):546-8. PubMed ID: 19539566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin-mediated interactions influence the tissue specificity of CD8+ cytolytic T lymphocytes.
    Rostapshova EA; Burns JM; Bartlett ST; Hadley GA
    Eur J Immunol; 1998 Oct; 28(10):3031-9. PubMed ID: 9808171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes.
    Yamashita N; Clement LT
    J Immunol; 1989 Sep; 143(5):1518-23. PubMed ID: 2474603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine requirements for production of a novel anti-CD8-resistant CTL population.
    Lamousé-Smith ES; Dougall DS; McCarthy SA
    J Immunol; 1999 Oct; 163(8):4160-7. PubMed ID: 10510351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation.
    Yuan R; El-Asady R; Liu K; Wang D; Drachenberg CB; Hadley GA
    J Immunol; 2005 Sep; 175(5):2868-79. PubMed ID: 16116173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation requirements, lytic mechanism, and development of a novel anti-CD8-resistant CTL population.
    McCarthy SA; Mainwaring MS; Dougall DS; Lamouse-Smith ES
    J Immunol; 1998 Mar; 160(6):2715-24. PubMed ID: 9510171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.
    Shacklett BL; Beadle TJ; Pacheco PA; Grendell JH; Haslett PA; King AS; Ogg GS; Basuk PM; Nixon DF
    Virology; 2000 May; 270(2):317-27. PubMed ID: 10792991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta 1-induced expression of the mucosa-related integrin alpha E on lymphocytes is not associated with mucosa-specific homing.
    Austrup F; Rebstock S; Kilshaw PJ; Hamann A
    Eur J Immunol; 1995 Jun; 25(6):1487-91. PubMed ID: 7614974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative immunohistochemical detection of CD103 (alphaEbeta7 integrin) in the infiltrates of acute rejection in liver and kidney transplantation.
    Leteurtre E; Copin MC; Labalette M; Noel C; Roumilhac D; Pruvot FR; Lecomte-Houcke M; Gosselin B; Dessaint JP
    Transplantation; 2000 Jul; 70(1):227-9. PubMed ID: 10919610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD103 identifies human regulatory T-cell subsets.
    Allakhverdi Z; Fitzpatrick D; Boisvert A; Baba N; Bouguermouh S; Sarfati M; Delespesse G
    J Allergy Clin Immunol; 2006 Dec; 118(6):1342-9. PubMed ID: 17137867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.